4//SEC Filing
Reumuth Mary 4
Accession 0001415889-24-000767
CIK 0001479419other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:04 PM ET
Size
10.2 KB
Accession
0001415889-24-000767
Insider Transaction Report
Form 4
KALA BIO, Inc.KALA
Reumuth Mary
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2024-01-04+4,600→ 67,363 total - Sale
Common Stock
2024-01-04$6.74/sh−1,227$8,270→ 66,136 total - Award
Stock Option (right to buy)
2024-01-04+20,500→ 20,500 totalExercise: $7.00Exp: 2034-01-03→ Common Stock (20,500 underlying)
Footnotes (6)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continued employment with the Issuer, the RSUs will vest as to 1/3 of the shares underlying the RSUs on January 4, 2025, as to 1/3 of the shares underlying the RSUs on January 4, 2026 and as to the final 1/3 of shares underlying the RSUs on January 4, 2027.
- [F2]Includes 65,156 unvested RSUs.
- [F3]This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's RSUs granted on January 4, 2023 and January 4, 2021.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.73 to $6.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F5]Includes 61,831 unvested RSUs.
- [F6]This option was granted on January 4, 2024 and vests over four years beginning on the vesting commencement date of January 4, 2024, with 1/48th the shares underlying the option vesting at the end of each successive one-month period thereafter until January 4, 2028, subject to the Reporting Person's continued employment with the Issuer.
Documents
Issuer
KALA BIO, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001710969
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:04 PM ET
- Size
- 10.2 KB